Development and validation of a seizure initiated drug delivery system for the treatment of epilepsy
RIS ID
111230
Abstract
Delivery of small dosages of anti-epileptic drug (AED) directly into the brain from implantable degradablepolymers has been reported to alleviate epilepsy activity in a GAERS animal model, however this systemdelivers a continuous dose of AED to the brain. We describe here the development of an active drugdelivery system whereby AED delivery is initiated by the onset of an epileptic event and controlled bya custom hardware device. The system is comprised of an electrocortigographic (ECoG) data receiver,computational hardware, and a drug delivery component. The system initiates the release of an AEDfrom an electrically conductive polymer when a seizure biomarker is detected above a pre-set threshold.Evaluation of the system showed that it is possible to vary the quantity of drug released linearly byvaring the amount of charge injected into the drug loaded electroactive polymer. In addition it is possibleto induce drug release within 10 s of injecting the charge, highlighting the responsive nature of thesystem. This work demonstrates a significant advance in the development of a device that combines theelectronics capable of monitoring ECoG activity, detecting epileptic seizures and initiating drug delivery.
Grant Number
ARC/CE140100012
Grant Number
ARC/FL110100196
Publication Details
Muller, R., Yue, Z., Ahmadi, S., Ng, W., Grosse, W. M., Cook, M. J., Wallace, G. G. & Moulton, S. E. (2016). Development and validation of a seizure initiated drug delivery system for the treatment of epilepsy. Sensors and Actuators B: Chemical: international journal devoted to research and development of physical and chemical transducers, 236 732-740.